https://pharmadog.xyz/news/336428 pharmadog en 2026-09-03T18:54:00.000Z B. Braun recalls three lots of 0.9% Sodium Chloride injection due to zinc oxide particles https://pharmadog.xyz/news/360447 pharmadog en 2026-09-03T18:49:58.000Z Merck's dealmaker warns of increased M&A activity as Keytruda patent expires https://pharmadog.xyz/news/360235 pharmadog en 2026-09-03T18:00:00.000Z New cardiovascular guidelines released for tactical athletes such as EMTs, firefighters and police https://pharmadog.xyz/news/359999 pharmadog en 2026-09-03T16:20:00.000Z Superluminal Medicines raises $60 million to advance AI-designed MC4R drug for rare obesity forms https://pharmadog.xyz/news/360000 pharmadog en 2026-09-03T16:01:00.000Z GSK to spend up to $1.3 billion on Hutchmed's dual-target cancer therapy https://pharmadog.xyz/news/359895 pharmadog en 2026-09-03T15:30:42.000Z Novartis licenses Alteogen’s hyaluronidase enzyme ALT-B4 in new drug delivery partnership https://pharmadog.xyz/news/359896 pharmadog en 2026-09-03T15:19:01.000Z Pfizer grants Medicus co-development rights to CD228-targeted ADC PF-08046031 https://pharmadog.xyz/news/134233 pharmadog en 2026-09-03T15:06:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/359919 pharmadog en 2026-09-03T15:01:02.000Z FDA grants emergency use authorization for Capstar and generic nitenpyram to prevent and treat New World screwworm in dogs and cats https://pharmadog.xyz/news/359812 pharmadog en 2026-09-03T14:53:00.000Z Ultragenyx to consider major cost cuts after Angelman drug fails trial https://pharmadog.xyz/news/359679 pharmadog en 2026-09-03T14:50:40.000Z AbbVie reports 60% reduction in progression risk for myeloma drug etentamig in Phase 3 trial https://pharmadog.xyz/news/359704 pharmadog en 2026-09-03T14:40:09.000Z TScan Therapeutics slashes 75% of staff as it pivots to solid tumor program https://pharmadog.xyz/news/359792 pharmadog en 2026-09-03T14:39:05.000Z Seattle researchers unveil $95 million AI biology initiative to map nature’s design rules https://pharmadog.xyz/news/359575 pharmadog en 2026-09-03T14:11:34.000Z Fauci warns of public "selective amnesia" on Covid, hints at upcoming book as STAT newsletter covers Trump drug pricing deals https://pharmadog.xyz/news/359555 pharmadog en 2026-09-03T14:06:40.000Z Revolution Medicines' Rasonque shows 42% response and 16-month survival in NSCLC subgroup https://pharmadog.xyz/news/359556 pharmadog en 2026-09-03T14:01:11.000Z ARPA-H allocates up to $125 million to accelerate personalized RNA therapy manufacturing https://pharmadog.xyz/news/359511 pharmadog en 2026-09-03T13:45:07.000Z Health tech investors shift focus to larger funding rounds, Cityblock secures $116 million https://pharmadog.xyz/news/359557 pharmadog en 2026-09-03T13:26:32.000Z Summit and Akeso's ivonescimab beats Merck's Keytruda in Chinese NSCLC trial https://pharmadog.xyz/news/359576 pharmadog en 2026-09-03T13:21:58.000Z HHS reverses stance on disability lawsuit amid reports of falling overdose deaths and AI device access https://pharmadog.xyz/news/359577 pharmadog en 2026-09-03T13:18:32.000Z OpenEvidence introduces new family of AI models for health tech https://pharmadog.xyz/news/359578 pharmadog en 2026-09-03T13:18:08.000Z Ultragenyx gene therapy for Angelman syndrome fails Phase 3 trial, company to cut expenses https://pharmadog.xyz/news/360002 pharmadog en 2026-09-03T13:14:12.000Z Akeso's ivonescimab shows survival advantage over Keytruda in Chinese lung cancer trial https://pharmadog.xyz/news/359535 pharmadog en 2026-09-03T12:52:49.000Z FDA requests public input to accelerate botanical drug product development https://pharmadog.xyz/news/359427 pharmadog en 2026-09-03T12:46:45.000Z GSK pays $110 million upfront for exclusive rights to HUTCHMED’s dual-target cancer therapy HMPL-A830 https://pharmadog.xyz/news/359339 pharmadog en 2026-09-03T12:00:00.000Z Scaling CAR-T: The hidden challenge of thousands of patient-specific manufacturing runs https://pharmadog.xyz/news/360146 pharmadog en 2026-09-03T11:58:00.000Z Psilocybin prevents chemotherapy-induced neuropathy in mouse study, effects last up to eight months https://pharmadog.xyz/news/359279 pharmadog en 2026-09-03T11:38:27.000Z Ultragenyx’s Angelman therapy fails Phase 3, stock drops over 43% and company announces strategic review https://pharmadog.xyz/news/359870 pharmadog en 2026-09-03T11:33:00.000Z Pfizer sells Seagen-derived ADC to Medicus Pharma for $12 million upfront, potential $1 billion milestones https://pharmadog.xyz/news/359280 pharmadog en 2026-09-03T11:29:39.000Z Senior FDA official overrides reviewers to grant Replimune accelerated approval for melanoma drug Tudriqev https://pharmadog.xyz/news/359118 pharmadog en 2026-09-03T11:12:36.000Z Akeso and Summit report ivonescimab meets overall survival endpoint in Phase 3 lung cancer trial https://pharmadog.xyz/news/359063 pharmadog en 2026-09-03T10:30:00.000Z Abivax remains independent despite intense acquisition speculation https://pharmadog.xyz/news/358851 pharmadog en 2026-09-03T10:00:59.000Z Superluminal Medicines raises $60M Series B to launch Phase 1 trial of genetic obesity therapy https://pharmadog.xyz/news/358852 pharmadog en 2026-09-03T09:59:27.000Z GSK licenses Hutchmed's KRAS-EGFR antibody-drug conjugate for $110 million upfront https://pharmadog.xyz/news/358895 pharmadog en 2026-09-03T09:39:01.000Z Benelux biotech strength hampered by fragmented investment, experts discuss path to unified corridor https://pharmadog.xyz/news/359486 pharmadog en 2026-09-03T08:42:00.000Z AbbVie’s bispecific T‑cell engager etentamig shows positive phase 3 results in relapsed/refractory multiple myeloma https://pharmadog.xyz/news/358789 pharmadog en 2026-09-03T08:30:00.000Z Former doula turned OB‑GYN calls for better understanding between the two professions https://pharmadog.xyz/news/358787 pharmadog en 2026-09-03T08:30:00.000Z FDA launches TEMPO pilot to let generative AI medical devices reach patients before formal approval https://pharmadog.xyz/news/358788 pharmadog en 2026-09-03T08:30:00.000Z FDA’s Biologics Branch Scores Wins Against Unproven Stem Cell Clinics, Says Expert https://pharmadog.xyz/news/358790 pharmadog en 2026-09-03T08:30:00.000Z Pediatricians Offer 'Last Resort' Care for Vaccine-Skeptical Parents https://pharmadog.xyz/news/358492 pharmadog en 2026-09-03T07:00:00.000Z Biopharma seeks data scientists as U.S. job market projected to grow 35% https://pharmadog.xyz/news/197927 pharmadog en 2026-09-03T07:00:00.000Z BioSpace lists top 12 biopharma employers hiring in July 2026 https://pharmadog.xyz/news/359210 pharmadog en 2026-09-03T05:07:00.000Z GSK agrees $1.3 billion deal with Hutchmed for early-stage KRAS-EGFR cancer candidate https://pharmadog.xyz/news/357959 pharmadog en 2026-09-03T04:02:00.000Z FDA advisory panels for Capricor and Replimune highlight need for rare-disease specialist input https://pharmadog.xyz/news/357979 pharmadog en 2026-09-03T04:01:00.000Z Overdose deaths fall sharply in US and abroad, report links decline to naloxone and harm-reduction measures https://pharmadog.xyz/news/359980 pharmadog en 2026-09-03T04:00:00.000Z FDA issues early alert on Draeger VentStar Resus Neo hoses due to crack risk and potential ventilation failure https://pharmadog.xyz/news/359979 pharmadog en 2026-09-03T04:00:00.000Z GE HealthCare updates use instructions for Portrait Mobile monitoring software after FDA safety alert https://pharmadog.xyz/news/359093 pharmadog en 2026-09-03T02:40:00.000Z Ultragenyx's Angelman gene therapy fails Phase 3, company to cut expenses https://pharmadog.xyz/news/357639 pharmadog en 2026-09-03T01:35:17.000Z Ultragenyx's Angelman syndrome drug fails Phase 3 trial, halting development https://pharmadog.xyz/news/356699 pharmadog en 2026-09-02T20:37:24.000Z Ultragenyx's Angelman syndrome drug fails in Phase 3 trial, showing no benefit https://pharmadog.xyz/news/356531 pharmadog en 2026-09-02T19:51:40.000Z FDA to tighten oversight of foreign clinical trial sites as China trial volume soars https://pharmadog.xyz/news/356487 pharmadog en 2026-09-02T19:21:51.000Z FDA vows tighter review of foreign clinical trial data amid rising Chinese influence https://pharmadog.xyz/news/356271 pharmadog en 2026-09-02T18:48:44.000Z Novartis CAR-T trial deaths spark safety concerns for autoimmune applications https://pharmadog.xyz/news/356059 pharmadog en 2026-09-02T16:32:00.000Z Novartis and Bristol Myers pause autoimmune CAR-T trials after serious safety events https://pharmadog.xyz/news/355827 pharmadog en 2026-09-02T16:02:32.000Z FDA CBER director overrides review team to grant accelerated approval for Replimune's melanoma therapy Tudriqev https://pharmadog.xyz/news/355931 pharmadog en 2026-09-02T15:22:00.000Z UniQure files FDA priority review request for Huntington’s gene therapy AMT-130 https://pharmadog.xyz/news/355700 pharmadog en 2026-09-02T15:07:53.000Z UK regulator suspends Tavneos sales as MHRA follows EMA decision; UniQure files for Huntington's gene therapy approval https://pharmadog.xyz/news/355611 pharmadog en 2026-09-02T14:58:42.000Z Teva's experimental antibody cuts intestinal damage in celiac patients after gluten challenge https://pharmadog.xyz/news/356462 pharmadog en 2026-09-02T14:48:00.000Z Fortrea acquires Worldwide Clinical Trials' early-phase division for $45 million https://pharmadog.xyz/news/360009 pharmadog en 2026-09-02T14:45:00.000Z Frutas y Hortalizas del Sur expands recall to include Great Value organic triple berry blend over possible E. coli O145 contamination https://pharmadog.xyz/news/355547 pharmadog en 2026-09-02T14:12:00.000Z Teva reports positive mid-stage results for celiac disease antibody, BioMarin settles patent fight with Ascendis https://pharmadog.xyz/news/355636 pharmadog en 2026-09-02T14:06:12.000Z Funding announcements can hint at upcoming biotech hiring opportunities https://pharmadog.xyz/news/355443 pharmadog en 2026-09-02T14:00:43.000Z Deaths of two Chinese children receiving CRISPR therapy spark safety debate https://pharmadog.xyz/news/355507 pharmadog en 2026-09-02T14:00:00.000Z Medical groups issue new flu, Covid and RSV vaccination guidance for upcoming winter season https://pharmadog.xyz/news/356246 pharmadog en 2026-09-02T13:45:00.000Z Novartis to cut about 130 jobs in Switzerland as it reshapes biologics production in Basel https://pharmadog.xyz/news/355508 pharmadog en 2026-09-02T13:37:50.000Z ARPA-H grants funding to biotech firms developing custom RNA therapies amid broader biotech updates https://pharmadog.xyz/news/355509 pharmadog en 2026-09-02T13:29:52.000Z Former ARPA-H director launches startup to solve AI's basic challenges in health care https://pharmadog.xyz/news/355510 pharmadog en 2026-09-02T13:26:55.000Z UniQure submits experimental Huntington's gene therapy to FDA for accelerated review https://pharmadog.xyz/news/355487 pharmadog en 2026-09-02T13:19:04.000Z UniQure submits FDA and UK applications for first Huntington’s disease gene therapy https://pharmadog.xyz/news/355359 pharmadog en 2026-09-02T12:06:07.000Z Beyond GLP-1s: Companies eye new obesity drug mechanisms as efficacy plateaus https://pharmadog.xyz/news/355231 pharmadog en 2026-09-02T11:59:16.000Z ADA internal review refutes censorship and police involvement allegations after conference ejections https://pharmadog.xyz/news/355211 pharmadog en 2026-09-02T11:38:48.000Z UK regulator suspends new patients from receiving Tavneos (Avacopan Vifor) amid data concerns https://pharmadog.xyz/news/355074 pharmadog en 2026-09-02T11:24:14.000Z Novartis’ BTK inhibitor remibrutinib cuts MS relapse rates in Phase 3, setting up FDA filing https://pharmadog.xyz/news/354951 pharmadog en 2026-09-02T11:00:57.000Z Typewriter secures $56M to advance jumping-gene platform and in vivo CAR-T therapies https://pharmadog.xyz/news/355586 pharmadog en 2026-09-02T10:29:00.000Z Teva's anti-IL-15 antibody meets primary endpoint in phase 2a celiac disease trial https://pharmadog.xyz/news/355588 pharmadog en 2026-09-02T10:17:00.000Z SEC and FDA sign three-year info-sharing pact to boost market integrity and public-health oversight https://pharmadog.xyz/news/355587 pharmadog en 2026-09-02T10:14:00.000Z TScan Therapeutics cuts 75% of staff to focus on preclinical solid tumor programs https://pharmadog.xyz/news/354827 pharmadog en 2026-09-02T09:52:38.000Z Novartis and BMS pause CAR‑T trials after patient deaths while Revolution Medicines gains early FDA approval for pancreatic cancer drug https://pharmadog.xyz/news/354721 pharmadog en 2026-09-02T08:30:00.000Z Experts urge next DSM to consider algorithmic influence on eating disorders https://pharmadog.xyz/news/354720 pharmadog en 2026-09-02T08:30:00.000Z Ig Nobel Prizes move to Zurich as organizers cite US immigration concerns https://pharmadog.xyz/news/354719 pharmadog en 2026-09-02T08:30:00.000Z Trump’s new pharma deals lower Medicaid prices but shield Medicare from cuts https://pharmadog.xyz/news/355310 pharmadog en 2026-09-02T07:51:00.000Z Novartis signs up to $3.2 billion deal with Korea's Alteogen for subcutaneous drug delivery technology https://pharmadog.xyz/news/354039 pharmadog en 2026-09-02T04:39:00.000Z Biotech reverse mergers surge 1,600% in Q3, matching number of IPOs in 2026 https://pharmadog.xyz/news/354040 pharmadog en 2026-09-02T04:18:00.000Z BMS faces steep risk if milvexian trial fails, could spark mega-cap merger frenzy https://pharmadog.xyz/news/356187 pharmadog en 2026-09-02T04:00:00.000Z FDA alerts AVID Medical users to correct convenience kits containing recalled sodium chloride ampules https://pharmadog.xyz/news/358937 pharmadog en 2026-09-02T04:00:00.000Z Medline expands recall of reprocessed electrophysiology and ultrasound catheters due to contamination risk https://pharmadog.xyz/news/356572 pharmadog en 2026-09-02T04:00:00.000Z Medline issues correction for convenience kits with potentially non-sterile BD ChloraPrep applicators https://pharmadog.xyz/news/358049 pharmadog en 2026-09-02T00:00:00.000Z EMA starts voluntary data-sharing pilot to boost confidence in new approach methods and cut animal testing https://pharmadog.xyz/news/353015 pharmadog en 2026-09-01T23:06:00.000Z ADA internal review rejects claims of silencing protest after member expulsions https://pharmadog.xyz/news/353016 pharmadog en 2026-09-01T23:00:00.000Z ADA reviews June conference disruptions, finds no censorship of editorial